1. Rise in serious ADE reports in the US

   Non-clinical study 09 February 2013 Pages: 1 - 1

2. Pfizer issues guidance on process impurity in Viracept

   News item 09 February 2013 Pages: 2 - 2

3. Haloperidol labelling updated

   News item 09 February 2013 Pages: 2 - 2

4. Important safety information highlighted for Fentora

   News item 09 February 2013 Pages: 2 - 2

5. New antidepressants linked to SGA neonates

   Clinical study 09 February 2013 Pages: 3 - 3

6. CV disorder risks extend beyond COX-2-selectivity of NSAIDs

   News item 09 February 2013 Pages: 3 - 3

7. Idraparinux effective, but risky, for venous thromboembolism

   Clinical study 09 February 2013 Pages: 4 - 4

8. Intrauterine levonorgestrel plus transdermal estrogen is not associated with an increase in C-reactive protein (CRP) levels

   Clinical study 09 February 2013 Pages: 4 - 4

9. Signals from the US FDA AERS database

   News item 09 February 2013 Pages: 4 - 4

10. Pioglitazone, rosiglitazone face up to MI, HF risk analyses

    News item 09 February 2013 Pages: 5 - 5

11. Adverse event profile similar for drug-eluting and bare-metal stents

    Clinical study 09 February 2013 Pages: 6 - 6

12. Alemtuzumab

    Case report 09 February 2013 Pages: 7 - 7

13. Acetazolamide

    Case report 09 February 2013 Pages: 7 - 7

14. Alemtuzumab/cyclophosphamide/fludarabine

    Case report 09 February 2013 Pages: 7 - 8

15. Amiodarone interaction

    Case report 09 February 2013 Pages: 8 - 8

16. Aripiprazole

    Case report 09 February 2013 Pages: 8 - 8

17. Antineoplastics

    Case report 09 February 2013 Pages: 8 - 8

18. Aspirin/clopidogrel/enoxaparin sodium

    Case report 09 February 2013 Pages: 9 - 9

19. Aspirin

    Case report 09 February 2013 Pages: 9 - 9

20. Aripiprazole

    Case report 09 February 2013 Pages: 9 - 9

21. Azathioprine

    Case report 09 February 2013 Pages: 10 - 10

22. Benzalkonium chloride

    Case report 09 February 2013 Pages: 10 - 10

23. Bevacizumab

    Case report 09 February 2013 Pages: 11 - 11

24. Bevacizumab

    Case report 09 February 2013 Pages: 11 - 11

25. Bleomycin

    Case report 09 February 2013 Pages: 12 - 12

26. Carbimazole/propylthiouracil/thiamazole

    Case report 09 February 2013 Pages: 12 - 12

27. Bortezomib

    Case report 09 February 2013 Pages: 12 - 12

28. Cefditoren pivoxil

    Case report 09 February 2013 Pages: 13 - 13

29. Ciprofloxacin

    Case report 09 February 2013 Pages: 13 - 13

30. Ciclosporin/mycophenolate mofetil/prednisone

    Case report 09 February 2013 Pages: 13 - 13

31. Corticosteroids

    Case report 09 February 2013 Pages: 14 - 14

32. Cotrimoxazole

    Case report 09 February 2013 Pages: 14 - 14

33. Clodronic acid

    Case report 09 February 2013 Pages: 14 - 14

34. Dexamethasone/diclofenac/paracetamol

    Case report 09 February 2013 Pages: 15 - 15

35. Dextromethorphan overdose/abuse

    Case report 09 February 2013 Pages: 15 - 15

36. Cyclophosphamide

    Case report 09 February 2013 Pages: 15 - 15

37. Dasatinib

    Case report 09 February 2013 Pages: 15 - 15

38. Erlotinib

    Case report 09 February 2013 Pages: 16 - 16

39. Erlotinib/gefitinib

    Case report 09 February 2013 Pages: 16 - 16

40. Erlotinib/gemcitabine

    Case report 09 February 2013 Pages: 16 - 17

41. Ethylmorphine hydrochloride/rocuronium bromide/suxamethonium chloride

    Case report 09 February 2013 Pages: 17 - 17

42. Exemestane/letrozole

    Case report 09 February 2013 Pages: 17 - 17

43. Etanercept

    Case report 09 February 2013 Pages: 17 - 17

44. Flurbiprofen/ketoprofen

    Case report 09 February 2013 Pages: 18 - 18

45. Fluorouracil

    Case report 09 February 2013 Pages: 18 - 18

46. Gadoteridol

    Case report 09 February 2013 Pages: 19 - 19

47. Ibuprofen

    Case report 09 February 2013 Pages: 20 - 20

48. Ganciclovir

    Case report 09 February 2013 Pages: 20 - 20

49. Imatinib

    Case report 09 February 2013 Pages: 20 - 20

50. Herbal medicines

    Case report 09 February 2013 Pages: 20 - 20